- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/70 - Sulfur atoms
Patent holdings for IPC class C07D 213/70
Total number of patents in this class: 329
10-year publication summary
13
|
27
|
24
|
19
|
17
|
16
|
18
|
22
|
9
|
9
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Sumitomo Chemical Company, Limited | 9027 |
18 |
Bristol-myers Squibb Company | 4872 |
10 |
Takeda Pharmaceutical Company Limited | 2707 |
8 |
BASF SE | 20874 |
6 |
LG Chem, Ltd. | 17581 |
6 |
Mitsui Chemicals Agro, Inc. | 88 |
6 |
Ardea Biosciences, Inc. | 73 |
6 |
Neurocrine Biosciences, Inc. | 401 |
6 |
Southern Research Institute | 210 |
6 |
Genentech, Inc. | 3976 |
5 |
Syngenta Crop Protection AG | 6045 |
5 |
Astellas Pharma Inc. | 1088 |
5 |
Celgene Quanticel Research, Inc. | 163 |
5 |
Inventisbio Co., Ltd. | 68 |
5 |
Curis, Inc. | 132 |
4 |
Ishihara Sangyo Kaisha, Ltd. | 659 |
4 |
Kotobuki Pharmaceutical Co., Ltd. | 38 |
4 |
Nihon Nohyaku Co., Ltd. | 325 |
4 |
Nippon Soda Co., Ltd. | 893 |
4 |
Taisho Pharmaceutical Co., Ltd. | 869 |
4 |
Other owners | 208 |